265 related articles for article (PubMed ID: 25140042)
21. Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing.
Zhang L; Zhang X; Zhang H; Liu F; Bi Y; Zhang Y; Cheng C; Liu J
Breast Cancer; 2020 May; 27(3):464-476. PubMed ID: 31919642
[TBL] [Abstract][Full Text] [Related]
22. Kinase suppressor of Ras 2 is involved in regulation of cell proliferation and is up-regulated in human invasive ductal carcinomas of breast.
Jia M; Souchelnytskyi S
Exp Oncol; 2010 Sep; 32(3):209-12. PubMed ID: 21403620
[TBL] [Abstract][Full Text] [Related]
23. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.
Chang HL; Lin JC
Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118550. PubMed ID: 31491447
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells.
Bowler E; Porazinski S; Uzor S; Thibault P; Durand M; Lapointe E; Rouschop KMA; Hancock J; Wilson I; Ladomery M
BMC Cancer; 2018 Apr; 18(1):355. PubMed ID: 29606096
[TBL] [Abstract][Full Text] [Related]
25. Elevated expression of the serine-arginine protein kinase 1 gene in ovarian cancer and its role in Cisplatin cytotoxicity in vitro.
Odunsi K; Mhawech-Fauceglia P; Andrews C; Beck A; Amuwo O; Lele S; Black JD; Huang RY
PLoS One; 2012; 7(12):e51030. PubMed ID: 23236423
[TBL] [Abstract][Full Text] [Related]
26. RNA-Binding Motif 4 (RBM4) Suppresses Tumor Growth and Metastasis in Human Gastric Cancer.
Yong H; Zhao W; Zhou X; Liu Z; Tang Q; Shi H; Cheng R; Zhang X; Qiu Z; Zhu J; Feng Z
Med Sci Monit; 2019 May; 25():4025-4034. PubMed ID: 31145716
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
28. Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.
Gout S; Brambilla E; Boudria A; Drissi R; Lantuejoul S; Gazzeri S; Eymin B
PLoS One; 2012; 7(10):e46539. PubMed ID: 23071587
[TBL] [Abstract][Full Text] [Related]
29. A novel chemical, STF-083010, reverses tamoxifen-related drug resistance in breast cancer by inhibiting IRE1/XBP1.
Ming J; Ruan S; Wang M; Ye D; Fan N; Meng Q; Tian B; Huang T
Oncotarget; 2015 Dec; 6(38):40692-703. PubMed ID: 26517687
[TBL] [Abstract][Full Text] [Related]
30. Kinome Profiling of Primary Endometrial Tumors Using Multiplexed Inhibitor Beads and Mass Spectrometry Identifies SRPK1 as Candidate Therapeutic Target.
Kurimchak AM; Kumar V; Herrera-Montávez C; Johnson KJ; Srivastava N; Davarajan K; Peri S; Cai KQ; Mantia-Smaldone GM; Duncan JS
Mol Cell Proteomics; 2020 Dec; 19(12):2068-2090. PubMed ID: 32994315
[TBL] [Abstract][Full Text] [Related]
31. Capillary morphogenesis gene 2 inhibits growth of breast cancer cells and is inversely correlated with the disease progression and prognosis.
Ye L; Sun PH; Malik MF; Mason MD; Jiang WG
J Cancer Res Clin Oncol; 2014 Jun; 140(6):957-67. PubMed ID: 24667935
[TBL] [Abstract][Full Text] [Related]
32. The far-upstream element-binding protein 2 is correlated with proliferation and doxorubicin resistance in human breast cancer cell lines.
Wang YY; Gu XL; Wang C; Wang H; Ni QC; Zhang CH; Yu XF; Yang LY; He ZX; Mao GX; Yang SY
Tumour Biol; 2016 Jul; 37(7):9755-69. PubMed ID: 26810065
[TBL] [Abstract][Full Text] [Related]
33. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
[TBL] [Abstract][Full Text] [Related]
34. CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor.
Funnell T; Tasaki S; Oloumi A; Araki S; Kong E; Yap D; Nakayama Y; Hughes CS; Cheng SG; Tozaki H; Iwatani M; Sasaki S; Ohashi T; Miyazaki T; Morishita N; Morishita D; Ogasawara-Shimizu M; Ohori M; Nakao S; Karashima M; Sano M; Murai A; Nomura T; Uchiyama N; Kawamoto T; Hara R; Nakanishi O; Shumansky K; Rosner J; Wan A; McKinney S; Morin GB; Nakanishi A; Shah S; Toyoshiba H; Aparicio S
Nat Commun; 2017 Feb; 8(1):7. PubMed ID: 28232751
[TBL] [Abstract][Full Text] [Related]
35. Aquaporin-5: a marker protein for proliferation and migration of human breast cancer cells.
Jung HJ; Park JY; Jeon HS; Kwon TH
PLoS One; 2011; 6(12):e28492. PubMed ID: 22145049
[TBL] [Abstract][Full Text] [Related]
36. SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells.
Wang C; Zhou Z; Subhramanyam CS; Cao Q; Heng ZSL; Liu W; Fu X; Hu Q
Commun Biol; 2020 May; 3(1):268. PubMed ID: 32461560
[TBL] [Abstract][Full Text] [Related]
37. Annexin-1 regulates growth arrest induced by high levels of estrogen in MCF-7 breast cancer cells.
Ang EZ; Nguyen HT; Sim HL; Putti TC; Lim LH
Mol Cancer Res; 2009 Feb; 7(2):266-74. PubMed ID: 19208747
[TBL] [Abstract][Full Text] [Related]
38. Ras suppressor-1 promotes apoptosis in breast cancer cells by inhibiting PINCH-1 and activating p53-upregulated-modulator of apoptosis (PUMA); verification from metastatic breast cancer human samples.
Giotopoulou N; Valiakou V; Papanikolaou V; Dubos S; Athanassiou E; Tsezou A; Zacharia LC; Gkretsi V
Clin Exp Metastasis; 2015 Mar; 32(3):255-65. PubMed ID: 25647720
[TBL] [Abstract][Full Text] [Related]
39. Serine-arginine protein kinase 1 is associated with breast cancer progression and poor patient survival.
Li XH; Song JW; Liu JL; Wu S; Wang LS; Gong LY; Lin X
Med Oncol; 2014 Aug; 31(8):83. PubMed ID: 24961466
[TBL] [Abstract][Full Text] [Related]
40. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
